![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, South Carolina
G protein-coupled receptor (GPCR)-G
fusion proteins were first characterized more than 10 years ago as a strategy for studying receptor-G protein signaling. A large number of studies have used this approach to characterize receptor coupling to members of the Gs, Gi, and Gq families of G
subunits, but this strategy has not been widely used to study G
12 and G
13. As described in the article by Zhang et al. in this issue of Molecular Pharmacology (p. 1433) characterization of the signaling properties of thromboxane A2 receptor (TP
) -G
12 and -G
13 fusion constructs demonstrates the applicability of this strategy to members of this unique family of G
subunits, and how this strategy can be used to resolve otherwise difficult problems of receptor pharmacology associated with these proteins. The general strategy of making receptor-G
fusion constructs has wide applicability to a number of research problems, but there are perhaps also "hidden messages" in how different receptor-G
subunit fusion pairs behave.
Address correspondence to: John D. Hildebrandt, Department of Cell and Molecular Pharmacology, Medical University of South Carolina, 173 Ashley Ave., 303BSB, Charleston, SC 29425. E-mail: hildebjd{at}musc.edu